Abstract
Increasingly, EUS has become integrated into the management of GI tumors over the past decade.1,2 The development of EUS-guided fine-needle aspiration3-5 and, more recently, EUS-guided fine-needle injection (EUS-FNI) has expanded the clinical utility of interventional EUS.6 EUS is traditionally not used to stage cancers in patients with esophageal or enteral self-expandable metallic stent (SEMS) because such patients have unresectable malignant disease. There is also a commonly held belief that EUS cannot be performed through an SEMS (Fig.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
